His scientific interests lie mostly in Pulmonary hypertension, Internal medicine, Pathology, Immunology and Cardiology. His Pulmonary hypertension study integrates concerns from other disciplines, such as Respiratory disease and Pulmonary wedge pressure, Pulmonary artery, Hemodynamics. In most of his Internal medicine studies, his work intersects topics such as Surgery.
His biological study deals with issues like Lung, which deal with fields such as Retrospective cohort study, Missense mutation, Channelopathy and Penetrance. He combines subjects such as Pulmonary pathology, Endothelial stem cell, Cancer research and Endothelial dysfunction with his study of Immunology. David Montani has researched Cardiology in several fields, including Potassium channel subfamily K member 3, Heritable pulmonary arterial hypertension and Anatomy.
David Montani focuses on Internal medicine, Pulmonary hypertension, Cardiology, Pulmonary artery and Hemodynamics. His Internal medicine research includes elements of Gastroenterology and Endocrinology. In his research, BMPR2 is intimately related to Pathology, which falls under the overarching field of Pulmonary hypertension.
His work deals with themes such as Blood pressure and Pulmonary function testing, which intersect with Cardiology. Hemodynamics is frequently linked to Retrospective cohort study in his study. Lung transplantation is a subfield of Transplantation that he explores.
The scientist’s investigation covers issues in Internal medicine, Pulmonary hypertension, Cardiology, Vascular resistance and Pulmonary artery. His research integrates issues of Gastroenterology and MEDLINE in his study of Internal medicine. David Montani has included themes like Ventricular pressure, Pathogenesis, Inflammation, Lung and In vivo in his Pulmonary hypertension study.
His Pulmonary embolism study in the realm of Cardiology interacts with subjects such as Large animal. The Vascular resistance study combines topics in areas such as Pulmonary wedge pressure, Combination therapy and Interstitial lung disease. His study looks at the intersection of Pulmonary artery and topics like Pulmonary Veno-Occlusive Disease with Pulmonary edema and Pulmonary vein.
Internal medicine, Pulmonary hypertension, Cardiology, Intensive care unit and Pneumonia are his primary areas of study. In the field of Internal medicine, his study on Vascular resistance, Hemodynamics, Hazard ratio and Chronic liver disease overlaps with subjects such as 2019-20 coronavirus outbreak. His Vascular resistance study combines topics from a wide range of disciplines, such as Mutation, Pulmonary wedge pressure, Combination therapy and Confounding.
His Pulmonary hypertension research focuses on subjects like Pulmonary artery, which are linked to Bone morphogenetic protein. His work on Cardiac index as part of general Cardiology research is frequently linked to Hypocapnia, bridging the gap between disciplines. His study on Intensive care unit also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi.
Circulation (2010)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Gérald Simonneau;Gérald Simonneau;David Montani;David Montani;David S. Celermajer;Christopher P. Denton.
European Respiratory Journal (2019)
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
M. Humbert;O. Sitbon;A. Yaïci;D. Montani.
European Respiratory Journal (2010)
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
David Montani;Emmanuel Bergot;Sven Günther;Laurent Savale.
Circulation (2012)
Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
Frédéric Perros;David Montani;Peter Dorfmüller;Ingrid Durand-Gasselin.
American Journal of Respiratory and Critical Care Medicine (2008)
A novel channelopathy in pulmonary arterial hypertension.
Lijiang Ma;Danilo Roman-Campos;Eric D. Austin;Mélanie Eyries.
The New England Journal of Medicine (2013)
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension.
David Montani;Laurent Savale;Delphine Natali;Xavier Jaïs.
European Heart Journal (2010)
Inflammation in Pulmonary Arterial Hypertension
Laura C. Price;S. John Wort;Frédéric Perros;Frédéric Perros;Peter Dorfmüller;Peter Dorfmüller.
Chest (2012)
Pulmonary veno-occlusive disease
David Montani;David Montani;Edmund M. Lau;Edmund M. Lau;Peter Dorfmüller;Barbara Girerd;Barbara Girerd.
European Respiratory Journal (2009)
Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation
Benjamin Sztrymf;Florence Coulet;Barbara Girerd;Azzedine Yaici.
American Journal of Respiratory and Critical Care Medicine (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Paris-Saclay
University of Paris-Saclay
University of Paris-Saclay
Université Paris Cité
Claude Bernard University Lyon 1
University of Cambridge
King's College London
University of Lille
Newcastle University
Hôpital de la Timone
George Washington University
University of Hannover
Grenoble Alpes University
University of Nebraska Medical Center
Texas A&M University
University of Padua
Dalian Institute of Chemical Physics
Walter Reed Army Institute of Research
Max Planck Society
United States Geological Survey
McGill University
Medical University of South Carolina
Wake Forest University
European Institute of Oncology
University of Bordeaux
University of Southern California